Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Liabilities and Shareholders Equity (2016 - 2025)

Milestone Scientific's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $8.5 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 24.06% year-over-year to $8.5 million; the TTM value through Sep 2025 reached $35.4 million, down 22.83%, while the annual FY2024 figure was $9.8 million, 13.85% down from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $8.5 million at Milestone Scientific, up from $8.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $22.6 million in Q1 2021 and bottomed at $8.1 million in Q2 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $12.0 million (2024), against an average of $13.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 255.18% in 2021 before it crashed 35.62% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $19.8 million in 2021, then tumbled by 30.83% to $13.7 million in 2022, then decreased by 17.01% to $11.4 million in 2023, then decreased by 13.85% to $9.8 million in 2024, then dropped by 13.38% to $8.5 million in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Liabilities and Shareholders Equity are $8.5 million (Q3 2025), $8.1 million (Q2 2025), and $9.1 million (Q1 2025).